Clinical Trial Update: Study Evaluating the Safety and Efficacy of Etanercept in Patients With Idiopathic Pulmonary Fibrosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of etanercept in patients with idiopathic pulmonary fibrosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Pulmonary Fibrosis

Drugs mentioned

• Etanercept (etanercept)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Pulmonary Fibrosis | Phase 2 | Status: COMPLETED